Table 1.
Baseline variables |
Survival status, N = 416 |
|||||
---|---|---|---|---|---|---|
|
Censored |
DEAD |
Total |
|||
N | % | N | % | N | ||
Sex (N = 416) |
|
|
|
|
|
|
Male |
190 |
48.00 |
10 |
50.00 |
200 |
48.10 |
Female |
206 |
52.00 |
10 |
50.00 |
216 |
51.90 |
Age at ART initiation (N = 416) |
|
|
|
|
|
|
≥120 months |
56 |
14.14 |
3 |
15.00 |
59 |
14.18 |
60-120 months |
140 |
35.35 |
4 |
20.00 |
144 |
34.62 |
36-59 months |
69 |
17.42 |
1 |
5.00 |
70 |
16.83 |
18-35 months |
73 |
18.43 |
4 |
20.00 |
77 |
18.51 |
<18 months |
58 |
14.65 |
8 |
40.00 |
66 |
15.87 |
Primary care giver (N = 402) |
|
|
|
|
|
|
Parents |
294 |
77.00 |
18 |
90.0 |
312 |
77.60 |
Relatives |
66 |
17.30 |
1 |
5.00 |
67 |
16.70 |
Guardians & Orphan |
22 |
5.80 |
1 |
5.00 |
23 |
5.70 |
Missing |
|
|
|
|
14 |
3.36 |
TB at baseline (416) |
|
|
|
|
|
|
Yes |
112 |
28.30 |
15 |
75.00 |
127 |
30.53 |
No |
284 |
71.72 |
5 |
25.00 |
289 |
69.47 |
Baseline WHO clinical stage (N = 416) |
|
|
|
|
|
|
stage I & II |
93 |
23.50 |
1 |
5.0 |
94 |
22.60 |
stage III |
187 |
47.20 |
14 |
70.0 |
201 |
48.30 |
stage IV |
116 |
29.30 |
5 |
25.0 |
121 |
29.10 |
CD4 percentage (N = 412) |
|
|
|
|
|
|
≥10% |
223 |
56.89 |
6 |
30 |
229 |
55.58 |
<10% |
169 |
43.11 |
14 |
70 |
183 |
44.42 |
Hemoglobin level (N = 408) |
|
|
|
|
|
|
≥8 g/dl |
363 |
93.56 |
15 |
75 |
378 |
92.65 |
<8 g/dl | 25 | 6.44 | 5 | 25 | 30 | 7.35 |